The Union health ministry has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, that would require manufacturers of antimicrobials to obtain central permission before they can. Draft rules mandate prior central approval for antimicrobials; exemptions proposed for medicinal gases, gelatin capsules and disinfectant. The Union Health Ministry proposed central licensing authority clearance for antibiotic production to curb antimicrobial resistance.